Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Aberrant placental ageing is implicated in a high percentage of birth complications, stillbirths and neonatal deaths. Understanding how this complex organ is established and maintained for the 9-10 months of pregnancy and then how and why it undergoes the physiological changes that result in labour at term is therefore of enormous clinical importance. In this review, we assess the evidence that placental ageing results from cellular senescence, a state of terminal proliferation arrest accompanied by characteristic morphological and metabolic changes including a shift to a pro-inflammatory phenotype. We discuss how senescence both contributes to placental formation during cytotrophoblast fusion, and to the changes necessary for labour onset, such as cervical remodelling and increased sterile inflammatory signalling. Based on evidence from human clinical studies and experimental interventions in mice, we assess possible biochemical pathways that may drive senescence, and speculate on how aberrant senescence in the placenta may contribute to pre-eclampsia, pre-term birth and stillbirth.

More information Original publication

DOI

10.1016/j.placenta.2017.01.116

Type

Journal article

Publication Date

2017-04-01T00:00:00+00:00

Volume

52

Pages

139 - 145

Total pages

6

Keywords

Aging, Decidua, IUGR, Inflammation, Placenta, Pre-eclampsia, Senescence, Senescence-associated secretory phenotype (SASP), Stillbirth, Syncytiotrophoblast, Animals, Cellular Senescence, Female, Humans, Inflammation, Placenta, Pre-Eclampsia, Pregnancy